Recurrent herpes labialis: developing drugs for treatment and prevention Recurrent herpes labialis: developing drugs for treatment and prevention

Collection: Health Policy and Services Research Series Title(s): Guidance for industry Contributor(s): United States. Department of Health and Human Services, issuing body. United States. Food and Drug Administration, issuing body. Center for Drug Evaluation and Research (U.S.), issuing body. Publication: Silver Spring, MD : Center for Drug Evaluation and Research, November 2017 Language(s): English Format: Text Subject(s): Antiviral Agents -- therapeutic use Clinical Trials as Topic Drug Evaluation, Preclinical Drugs, Investigational -- therapeutic use Herpes Labialis -- drug therapy Herpes Labialis -- prevention & control United States United States. Department of Health and Human Services United States. Food and Drug Administration Genre(s): Guideline Technical Report Copyright: The National Library of Medicine believes this item to be in the public domain. (More information) Extent: 1 online resource (1 PDF file (19 pages)). NLM Unique ID: 101719926 (See catalog record) Permanent Link: http://resource.nlm.nih.gov/101719926